Assessment of Corneal Cross-Linking Effect on Progressive Keratoconus by Using the ABCD Grading System

Autor: Alzahrani M, Alammari O, Binyamin A, Alsulami R, Hawsawi R

Publikováno v: Clinical Ophthalmology, Vol Volume 18, Pp 2349-2355 (2024)

Mazen Alzahrani,1 Omer Alammari,2 Abdulelah Binyamin,3 Raed Alsulami,1 Rawan Hawsawi2 1Department of Anterior Segment, Jeddah Eye Hospital, Jeddah, Saudi Arabia; 2Department of Anterior Segment, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arab

Externí odkaz: https://doaj.org/article/c08cab4d8242451f9e31da08374a331c

Early Cytokine Signatures of Hospitalized Mild and Severe COVID-19 Patients: A Prospective Observational Study

Autor: Alfadda AA, Siddiqui K, Rafiullah M, AlKhowaiter M, Alotaibi N, Alzahrani M, Binkhamis K, Youssef AM, Altalhi H, Almaghlouth I, Alarifi M, Albanyan S, Alosaimi MF, Isnani A, Nawaz SS, Alayed K

Publikováno v: Journal of Inflammation Research, Vol Volume 16, Pp 2631-2643 (2023)

Assim A Alfadda,1– 3 Khalid Siddiqui,2 Mohamed Rafiullah,2 Mohammad AlKhowaiter,1 Naif Alotaibi,4 Musa Alzahrani,5 Khalifa Binkhamis,6 Amira M Youssef,2 Haifa Altalhi,7 Ibrahim Almaghlouth,8 Mohammed Alarifi,9 Saleh Albanyan,1 Mohammed F Alosaimi,1

Externí odkaz: https://doaj.org/article/bdff6db6b7b34e40bb274d8824b5145e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Herpes simplex virus reactivation among hematopoietic stem cell transplant recipients: re-evaluating acyclovir dosage.

Autor: Alsuhebany N; Department of Pharmaceutical Care, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alshehri B; Department of Pharmaceutical Care, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia., Aldairem A; Department of Pharmaceutical Care, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Aleissa MM; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. mmaleissa@pnu.edu.sa., AlQahtani H; Department of Pharmaceutical Care, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Albarqi K; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Almotairi B; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., AlAmri M; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alanazi W; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alay S; College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alahmari B; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Department of Oncology, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia., Alzahrani M; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Department of Oncology, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2024 Jul; Vol. 59 (7), pp. 1043-1045. Date of Electronic Publication: 2024 Apr 16.

Favorable outcome of non-myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patients.

Autor: Damlaj M; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.; Blood and Cancer Research Unit, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Division of Hematology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE.; College of Medicine, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE., Alahmari B; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.; Blood and Cancer Research Unit, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alaskar A; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.; Blood and Cancer Research Unit, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alhejazi A; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.; Blood and Cancer Research Unit, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alsadi H; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Ahmed M; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alanazi T; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Ahmed R; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alharbi A; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Shehabeddine I; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alzaidi A; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alkhuraisat S; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Mahassnah I; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alquraan H; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Ballili M; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alzahrani M; Division of Hematology, King Abdulaziz Medical City - Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.; Blood and Cancer Research Unit, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Jun; Vol. 99 (6), pp. 1023-1030. Date of Electronic Publication: 2024 Mar 15.